英文别名:
1H-Imidazole,2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-4,5-dihydro-;Efaroxan;2-(2-ethyl-3H-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole;2-(2-ethyl-3H-benzofuran-2-yl)-4,5-dihydro-1H-imidazole;2-[(2-Ethyl-2,3-dihydrobenzofuran)-2-yl]-4,5-dihydro-1H-imidazole;1H-Imidazole, 2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-4,5-dihydro-;NSC 759562;KBio2_005129;CHEBI:93806;Tox21 110139;AB00918533_03;Efaroxanum;SDCCGSBI-0050504.P003;NCGC00015410-05;Efaroxanum (INN-Latin);NCGC00015410-13;KBioSS_002570;Tox21_110139;2-(2-Ethyl-2,3-dihydrobenzofuran-2-yl)-4,5-dihydro-1H-imidazole;2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-4,5-DIHYDRO-1H-IMIDAZOLE;NSC-759562;Spectrum3_001863;DTXSID8045149;CHEMBL57895;G00490L21H;UNII-G00490L21H;RX 821037;KBio3_002808;SCHEMBL127096;BRD-A10739734-003-10-6;NCGC00024793-03;DTXCID6025149;Tox21_110139_1;Efaroxano;SBI-0050504.P002;CAS-89197-32-0;RATZLMXRALDSJW-UHFFFAOYSA-N;Lopac0_000521;BSPBio_003306;(+-)-2-(2-Ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline;Efaroxano [INN-Spanish];BDBM50179393;89197-32-0;Efaroxan (hydrochloride);EFAROXAN [INN];NCGC00015410-03;(+/-)-2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline;MRF-0000021;KBio2_002561;BRD-A10739734-003-05-6;Spectrum_001997;NCGC00015410-04;BRD-A10739734-003-09-8;KBio2_007697;HMS2089D15;Efaroxano (INN-Spanish);2-((2-ethyl-2,3-dihydrobenzofuran-2-yl))-2-imidazoline;L001351;NCGC00015410-06;NCGC00024793-02;NS00124896;Q5347187;CCG-204611;NCGC00015410-08;Efaroxan [INN:BAN];Efaroxanum [INN-Latin];2-(2-ethyl-2,3-dihydro-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole;
Inchi:
1S/C13H16N2O/c1-2-13(12-14-7-8-15-12)9-10-5-3-4-6-11(10)16-13/h3-6H,2,7-9H2,1H3,(H,14,15)